Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation

British Journal of Clinical Pharmacology

Volumn 60, Issue 5, 2005, Pages 573-577

  Brunner, Martin ^a   Dehghanyar, Pejman ^a   Seigfried, Bernd ^b   Martin, Wolfgang ^c   Menke, Georg ^d   Müller, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MIKA Pharma GmbH   (Germany)

^c Pharmakin GmbH   (Germany)

^d Department of Oral   (Germany)

Author keywords

Dermal penetration; Diclofenac; Microdialysis; Spray gel; Topical

Indexed keywords

DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG PENETRATION; DRUG SCREENING; DRUG TOLERABILITY; ENTERIC COATED TABLET; GEL; HUMAN; IN VIVO STUDY; MALE; MICRODIALYSIS; MUSCLE TISSUE; NEBULIZATION; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN PENETRATION; SUBCUTANEOUS TISSUE; TOPICAL TREATMENT;

ADIPOSE TISSUE; ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; AEROSOLS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; DICLOFENAC; GELS; HUMANS; MALE; MUSCLE, SKELETAL; PROSPECTIVE STUDIES; SKIN ABSORPTION; TABLETS;

EID: 27444441496     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2005.02484.x     Document Type: Article

References (22)

1. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999; 340 (24): 1888-99.
2. Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs 2000; 60 (3): 555-74.
3. Müller M, Rastelli C, Ferri P, Jansen B, Breiteneder H, Eichler HG. Transdermal penetration of diclofenac after multiple epicutaneous administration. J Rheumatol 1998; 25: 1833-6.
4. Morgan CJ, Renwick AG, Friedmann PS. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis. Br J Dermatol 2003; 148 (3): 434-43.
5. Riess W, Schmid K, Botta L, Kobayashi K, Moppert J, Schneider W, Sioufi A, Strusberg A, Tomasi M. The percutaneous absorption of diclofenac. Arzneimittelforschung 1986; 36 (7): 1092-6.
6. Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 1998; 316 (7128): 333-8.
7. Artmann C. Verteilung und Deposition von Diclofenac. In-vivo- Untersuchungen zur Verteilung und Deposition auf der menschlichen Rückenhaut mit verschiedenen galenischen Zubereitungen von Diclofenac. Wissenschaftlicher Kurzbericht Nr. 97003, 14.03.1997. MIKA Pharma data on file.
8. Link R. Placebo-controlled clinical multicentre study to verify efficacy and safety of Diclofenac Spray Gel 4% MK in the treatment of ankle distortions, MIKA Pharma data on file, 2000.
9. Müller M. Science medicine, and the future: Microdialysis. BMJ 2002; 324 (7337): 588-91.
10. Shah VP. Topical drug products - microdialysis: regulatory perspectives. Int J Clin Pharmacol Ther 2004; 42 (7): 379-81.
11. Lönnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 1987; 253: E228-31.
12. Davies NM, Anderson KE. Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls. Clin Pharmacokinet 1997; 33 (3): 184-213.
13. Radermacher J, Jentsch D, Scholl MA, Lustinetz T, Frolich JC Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 1991; 31 (5): 537-41.
14. Zacher J, Feldman D, Gerli R, Scott D, Hou SM, Uebelhart D, Rodger IW, Ozturk ZE, Etoricoxib OA Study Group. A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis. Curr Med Res Opin 2003; 19 (8): 725-36.
15. Arcangeli P, Andreotti L, Palazzini E. Effective treatment of osteoarthritis with a 150 mg prolonged-release formulation of diclofenac sodium. Riv Eur Sci Med Farmacol 1996; 18 (5-6): 217-23.
16. Stahle L, Arner P, Ungerstedt U. Drug distribution studies with microdialysis. III. Extracellular concentration of caffeine in adipose tissue in man. Life Sci 1991; 49 (24): 1853-8.
17. Guy RH, Hadgraft J, Bucks DA. Transdermal drug delivery and cutaneous metabolism. Xenobiotica 1987; 17 (3): 325-43.
18. Borg N, Gotharson E, Benfeldt E, Groth L, Stahle L. Distribution to the skin of penciclovir after oral famciclovir administration in healthy volunteers: comparison of the suction blister technique and cutaneous microdialysis. Acta Derm Venereol 1999; 79 (4): 274-7.
19. Tegeder I, Muth-Selbach U, Lotsch J, Rusing G, Oelkers R, Brune K, Meller S, Kelm GR, Sorgel F, Geisslinger G. Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther 1999; 65 (4): 357-68.
20. Benfeldt E, Serup J. Effect of barrier perturbation on cutaneous penetration of salicylic acid in hairless rats: in vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function. Arch Dermatol Res 1999; 291 (9): 517-26.
21. Schnetz E, Fartasch M. Microdialysis for the evaluation of penetration through the human skin barrier - a promising tool for future research? Eur J Pharm Sci 2001; 12 (3): 165-74.
22. Wester RC, Maibach HI. Percutaneous absorption of drugs. Clin Pharmacokinet 1992; 23 (4): 253-66.